MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.5861 +0.0097 (+1.68%)
Official Closing Price Updated: 8:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action ↗
Oragenics Inc (NYSE: OGEN) announced the results from its hamster challenge study to evaluate the COVID-19 vaccine candidate. The study is assessing the... 
Via Benzinga
News headline image
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
News headline image
Why Did Oragenics Shares Skyrocket Tuesday? ↗
Oragenics Inc. (NYSE:OGEN) shares skyrocketed higher Tuesday... 
Via Benzinga
News headline image
20 Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the FDA approved expanded labeling for Caldolor to... 
Via Benzinga
News headline image
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
News headline image
25 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 95.1% to $23.22 in pre-market trading after jumping around 24% on Monday. Diginex Limited (NASDAQ: EQOS) rose 74.5% to $7.... 
Via Benzinga
News headline image
Oragenics Awarded a $250,000 Grant from the National Institute of General Medical Sciences (NIGMS) for the Continued Research and Development of Lantibiotics.
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Launches Animal Study For COVID-19 Vaccine Candidate ↗
Oragenics Inc (NYSE: OGEN) has initiated a hamster challenge study to evaluate the immunogenicity and viral load reduction impact of its COVID-19 vaccine candidate... 
Via Benzinga
News headline image
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
News headline image
48 Biggest Movers From Yesterday ↗
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming... 
Via Benzinga
News headline image
Oragenics's New Preclinical Data Supports Its Approach For COVID-19 Vaccine Development ↗
Oragenics Inc's (NYSE: OGEN) stabilized pre-fusion spike protein trimer generates neutralizing antibodies in mice after immunization against SARS-CoV-2 when... 
Via Benzinga
News headline image
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice with Intramuscular and Intranasal Adjuvants
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Announces Postponement of Annual Meeting of Shareholders
From Oragenics, Inc.
Via Business Wire
News headline image
28 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares rose 38.2% to $2.10 in pre-market trading. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
News headline image
Mid-Afternoon Market Update: Nasdaq Tumbles 240 Points; Oragenics Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded down 0.50% to 34,969.30 while the NASDAQ fell 1.62% to 14,600.30. The S&P also fell, dropping 0.80% to 4,387.07. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
50 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... 
Via Benzinga
News headline image
Mid-Day Market Update: GasLog Partners Drops After Q2 Results; EyeGate Pharmaceuticals Shares Jump ↗
Midway through trading Tuesday, the Dow traded down 0.51% to 34,963.96 while the NASDAQ fell 1.85% to 14,565.52. The S&P also fell, dropping 0.81% to 4,386.41. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
Via Benzinga
News headline image
44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
News headline image
OGEN Stock: The Covid Vaccine News That Has Oragenics Shooting Higher Today ↗
Oragenics (OGEN) stock is surging higher on Tuesday following news that the company is developing a new vaccine for the novel coronavirus. 
Via InvestorPlace
News headline image
Oragenics Stock Is Trading Higher On Licensing, Material Transfer Pact For Rapid Development Of COVID-19 Vaccine ↗
Oragenics Inc (NYSE: OGEN) has entered into a licensing agreement with the National Research Council of Canada (NRC), allowing Oragenics to develop next-generation... 
Via Benzinga
News headline image
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
News headline image
Oragenics Issues Letter to Shareholders
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Announce Changes in Management and Board of Directors
From Oragenics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story